High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients

James L. Weeks,Roya Zoraghi,Alfreda Beasley,Konjeti R. Sekhar,Sharron H. Francis,Jackie D. Corbin

High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients

2005

James L. Weeks
Roya Zoraghi
Alfreda Beasley
Konjeti R. Sekhar
Sharron H. Francis
Jackie D. Corbin

High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients

Keywords:

Sildenafil
Selectivity
Enzyme
Vardenafil
Endocrinology
Internal medicine
Diabetes mellitus
Phosphodiesterase
Enzyme inhibitor
Medicine
Tadalafil
in patient
cross reactions

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations